Astronics Earnings Call Transcripts
Fiscal Year 2026
-
Q2 records in sales, bookings, and backlog underpin a raised FY26 revenue outlook of $1.02 billion-$1.04 billion. Seat Motion, flight-critical power, and military test programs add growth drivers into 2027 and beyond.
-
Record Q2 results featured all-time highs in revenue, profit, bookings, and backlog, with adjusted EBITDA margin nearing 20%. Raised full-year revenue guidance to $1.02–$1.04 billion, driven by strong aerospace and test systems performance and robust market demand.
-
Q1 2026 delivered strong revenue and margin growth, record bookings, and a raised full-year outlook, driven by broad-based demand in aerospace and test systems. Backlog and book-to-bill ratios reached all-time highs, with no current impact from geopolitical conflicts.
-
Aerospace-focused supplier expects strong growth into 2026, driven by record backlog, robust retrofit demand, and major programs like FLRAA. Financials have rebounded post-pandemic, with improved margins, a strengthened balance sheet, and a flexible M&A approach.
-
Strong recovery and record revenues are driven by commercial aerospace demand, robust backlog, and strategic defense programs. Guidance for 2026 anticipates 10%-15% growth, with diversification into defense, eVTOL, and drone markets supporting future upside.
-
Strong growth in aerospace and test segments, robust order backlog, and recent acquisitions support a positive outlook for 2026. Financial performance is improving, with enhanced profitability, reduced debt costs, and major industry programs driving future expansion.
Fiscal Year 2025
-
Record Q4 revenue and margins capped a strong year, with 2025 adjusted operating margin up to 12.2% and robust cash flow. 2026 guidance calls for 12.5%–15% revenue growth, continued margin expansion, and strong demand in aerospace and test systems.
-
Revenue reached $211.4 million, with strong margins and cash flow, driven by broad demand and operational improvements. Backlog remains high, and acquisitions plus refinancing actions have enhanced capabilities and reduced dilution risk. Q4 and 2026 are expected to see significant growth.
-
Aerospace and test segments are recovering strongly post-pandemic, with record aerospace sales, robust backlog, and major new programs like FLRAA on the horizon. Financial performance is improving, supported by strong liquidity and capital investment plans.
-
Second quarter sales rose 3.3% year-over-year, led by record aerospace results, while test segment performance was impacted by a $6.8 million adjustment. 2025 revenue guidance was raised to $840–$860 million, with strong aerospace momentum and improved margins expected to drive a robust second half.
-
Q1 2025 saw double-digit revenue growth, record bookings, and margin expansion, led by aerospace. Guidance for 2025 is maintained, but tariff and legal risks remain. Strong cash flow and liquidity support ongoing investments and operational improvements.
-
Aerospace-focused supplier reported strong post-pandemic growth, with sales and margins improving through 2024 and a healthy $600M+ backlog. Strategic cost reductions, a new bond offering, and a major new defense program support a positive 2025 outlook, despite ongoing legal risks.
-
Aerospace and test equipment sales have rebounded to pre-pandemic levels, with 2025 growth expected to moderate. Key military programs and improved supply chain efficiency support future prospects, while ongoing patent litigation is well-capitalized for potential outcomes.
Fiscal Year 2024
-
Q4 and full-year 2024 saw strong sales and margin expansion, driven by record aerospace results and operational improvements. Legal and restructuring charges impacted reported results, but adjusted metrics showed significant gains. 2025 guidance remains robust, with higher CapEx planned for growth.
-
Leadership transition is underway as the company recovers from pandemic lows, with strong growth in aerospace and test systems. Margins and backlog are improving, aided by contract repricing and a recent convertible note. Key risks include Boeing order delays and a pending UK lawsuit.
-
Third quarter sales rose 25% year-over-year, with strong margin improvements and adjusted net income of $12.2M. Legal and warranty charges impacted GAAP results, but underlying business performance was robust, and full-year sales are forecast to grow over 14%.
-
Aerospace and test systems provider has rebounded from pandemic lows, with strong bookings, improving margins, and a robust backlog. Growth is driven by leading positions in in-flight power, new military contracts, and recovery in commercial aerospace.
-
Q2 2024 delivered strong sales growth, margin improvement, and record bookings, with robust aerospace performance and a major test segment contract win. Full-year revenue guidance was raised, liquidity improved via refinancing, and cash flow is expected to strengthen in H2.